Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Operating Leases (2019 - 2025)

Nephros (NEPH) has 6 years of Operating Leases data on record, last reported at $1.1 million in Q4 2024.

  • For Q4 2024, Operating Leases fell 23.53% year-over-year to $1.1 million; the TTM value through Dec 2024 reached $1.1 million, down 23.53%, while the annual FY2024 figure was $1.1 million, 23.53% down from the prior year.
  • Operating Leases reached $1.1 million in Q4 2024 per NEPH's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $1.4 million in Q4 2023 and bottomed at $340000.0 in Q4 2021.
  • Average Operating Leases over 5 years is $840250.0, with a median of $873500.0 recorded in 2020.
  • Peak YoY movement for Operating Leases: crashed 55.2% in 2021, then soared 107.35% in 2022.
  • A 5-year view of Operating Leases shows it stood at $759000.0 in 2020, then plummeted by 55.2% to $340000.0 in 2021, then skyrocketed by 107.35% to $705000.0 in 2022, then soared by 97.16% to $1.4 million in 2023, then dropped by 23.53% to $1.1 million in 2024.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $1.1 million in Q4 2024, $1.2 million in Q3 2024, and $1.3 million in Q1 2024.